Skip to main content

Clinical trial MO29112_MODUL

A multi-centre randomized clinical trial of Biomarker-Driven maintenance treatment for first-line metastatic colorectal cancer (MODUL).

Organ colorectal
Trial status Trial open for recruitment
Trial type
Prospective interventional
Phase Trial phase 2
Academic trial Non
Sponsor Roche
EudraCT Identifier 2014-001017-61
Inclusion criteria first line RECIST 1.1
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more